Insmed (INSM) Assets Average (2011 - 2026)
Insmed (INSM) recorded quarterly Assets Average of $2.2 billion in Q1 2026, down 6.16% quarter-over-quarter from $2.3 billion in Q4 2025, and up 13.39% on a YoY basis from $1.9 billion in Q1 2025.
Insmed (INSM) Assets Average (2011 - 2026) Analysis & Trends
Insmed's Assets Average history runs 16 years deep, the most recent figure standing at $2.2 billion for Q1 2026.
- In Q1 2026, Assets Average rose 13.39% year-over-year to $2.2 billion; the TTM figure through Mar 2026 stood at $2.2 billion (up 13.39% YoY), while the FY2025 annual figure was $2.1 billion, up 27.86% from the prior year.
- Assets Average was $2.2 billion for Q1 2026 at Insmed, down from $2.3 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $2.4 billion in Q3 2025 to a low of $1.0 billion in Q3 2022.
- Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.5 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 61.02% in 2022, then slipped 21.59% in 2024.
- A 5-year view of Assets Average shows it stood at $1.3 billion in 2022, then climbed by 0.13% to $1.3 billion in 2023, then soared by 53.62% to $2.0 billion in 2024, then increased by 13.42% to $2.3 billion in 2025, then slipped by 6.16% to $2.2 billion in 2026.
- The last three Assets Average figures came in at $2.2 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 2.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.17 Bn |
| Dec 31, 2025 | 2.31 Bn |
| Sep 30, 2025 | 2.42 Bn |
| Jun 30, 2025 | 2.14 Bn |
| Mar 31, 2025 | 1.91 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 1.93 Bn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.59 Bn |
| Dec 31, 2022 | 1.33 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.10 Bn |
| Mar 31, 2022 | 1.20 Bn |
| Dec 31, 2021 | 1.28 Bn |
| Sep 30, 2021 | 1.27 Bn |
| Jun 30, 2021 | 961.09 Mn |